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ABSTRACT 
Hepato-cutaneous porphyria can be induced in weanling pigs. The collidine deriva-
tive, DDC, produces proto porphyria in these animals, associated with photosensitivity. 
This porphyria is characterized by accumulation of protoporphyrin in the bile and 
liver. Fecal protoporphyrin excretion is markedly increased. The levels of proto-
prophyrin in the bile and liver are dependent on the dosage level of DDC. Erythro-
cyte protoporphyrin levels are not elevated. Protoporphyrin in the pla rna and skin 
of animals on the maximal DDC dose was demonstrated. There wa no significant 
elevation of urinary porphyrins in the experimental pigs. 
In studies of chemical or drug induced 
porphyria, special biological parameters are re-
quired of the experimental animal model. The 
usceptibility of the animal to the disease trait 
i the primary requisite and it is desirable that 
the data can be extrapolated realistically to 
man. The ease of accurate oral drug adminis-
tration, as well as the collection of blood, bile, 
urine and fecal samples, may determine selec-
tion. Whereas chemical porphyrias of the 
hepatic and erythropoietic types have been in-
duced in rats and mice and these small labora-
tor~' animals confer the obvious advantages of 
Pconomy and availability, they are not ideal 
for the induction of porphyrias characterized 
b~· increased fecal output of porphyrins owing 
to their habit of coprophagy and the recycling 
of endogenous porphyrins (1). Further, vi ual 
a;:;:s1y of the skin response to irradiation is un-
reliable in these animal (2). 
The choice of ·weanling pigs for the current 
~tudy of porphyria was made not only because 
geneti cally determined porphyria has been re-
ported in this animal . pecie (3, 4, 5), but also 
because baby pigs possess the attributes neces-
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sary to such investigations. They can be kept in 
small metabolism cages, and will swallow drugs 
or chemicals in capsule form. It was predicted 
that direct visual evaluation of photosensitivity 
reactions might be facilitated by the character 
of the integument. 
The collidine derivative, diethyl 1, 4-dihydro-
2,4,6- trimethylpyridine- 3, 5- dicarboxylate 
(DDC) was used as the porphyrogenic agent 
in these studies. This compound has been 
hown to induce an acute disorder of pyrrole 
metabolism in the rat (6), mouse (6a, 7, 8) and 
in the guinea pig (9). In the mouse, DDC-in-
duced porphyria i characteriz.ed by elevation 
of fecal and erythrocyte porphyrin , a condi-
tion similar to experimental griseofulvin por-
phyria and to erythropoietic protoporphyria 
m man. 
METHOD S A~D MATERIALS 
Female Yorkshire pigs were used in four studies 
except in one instance where a single female minia-
ture pig was included. Eleven experimental and 
six control animals were studied. The pigs were 
weaned at 9 to 11 days; at which time they had an 
average weight of 2 kg. They were housed individ-
ually in rabbit metabolism cages, which were 
shielded from light by aluminum foil. The animals 
were given Spf Borden formula in three equal 
feedings. This food wa supplied initially at a level 
of 10 % of the body weight by volume per day and 
the intake was increased to meet grmvth require-
ments. 
In the initial study the effects of administration 
of DDC to both a Yorkshire and a miniature pig 
were followed in order to test whether porphyria 
could be induced in two genetic strains. Subsequent 
studies utilized litter-mate animals and included 
control pigs who did not receive the drug. Com-
plete 24-hourly urinary and fecal excretions were 
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TABLE I 
Summary of studies of DDC-induced porphyria in weanling pigs 
o. animals 
Investigation 
Experi-
mental 
1. Porphyria induction in different strains 2 
2. Abnormal porphyrin excretion and tissue 1 
depo ition. DDC-treated vs control pigs 
3. Photosensitivity associated with DDC- 2 
induced porphyria 
4. Dose-dependent parameters 6 
collected. Blood samples were obtained from the 
pre-caval vein. Recrystallized DDC was adminis-
tered in gelatin capsules. Three dosage levels of the 
drug were employed, viz., 100, 200 and 400 mgjkg (Table I). In all studies, DDC administration was 
commenced after baseline determinations of uri-
nary, fecal and blood porphyrins had been ob-
tained. 
Tests of skin photosensitivity were carried out 
Strain DDC dose Duration of 
mg/kg study (days) 
Control 
0 Miniature 200 27 
Yorkshire 
2 Yorkshire 200 32 
2 Yorkshire 200 33 
2 Yorkshire 100 (2) 
200 (2) 
400 (2) 22 
by exposure to "blue light" from the F40B, General 
Electric fluorescent lamp, having two parallel 48" 
tubes. This lamp has a maximal spectral energy 
emission between 400 and 500 mp. (Fig. 1). The 
pigs were shaved before each irradiation and re-
strained in a box so that they were at a constant 
distance from the lamp. Except in the first study, 
control and experimental animals were irradiated 
at the same time. Irradiation was carried out both 
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FIG. 1. pectral ener distribution ofF 40B G.E. "Blue" lamps. The animals were irradi-at d at a con tant kin distance of 32 em. The incident illumination on the inadiated sites wa 123 ]urn ns/ sq.m. (measured with the Weston Illuminometer, Model603). 
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before and after initiation of DDC administration. 
The duration of "blue light" exposure varied from 
one to six hours. 
The overall length of the studies was from 22 to 
33 days. Animals were sacrificed by section of the 
neck veins and arteries following barbiturate anes-
thesia . The skin, hair, viscera, bone and bone mar-
row were inspected under Wood's light for charac-
teristic porphyrin fluorescence. The wet weights of 
the liver, spleen and kidneys were obtained. The 
contents of the gall bladder were aspira~d. 
Skin biopsies, obtained after "blue light" ir-
radiation, and postmortem tissue samples from 
the liver, kidney, spleen. lung and bone marrow, 
'"ere processed for histological examination after 
fixation in Bouin's solution. Both paraffin and 
frozen sections of the selected tissues were made. 
Routine hematoxylin and eosin stained sections 
"·ere examined by light microscopy and by polar-
ized optical methods using a Zeiss microscope. 
Unstained sections were studied by fluorescence 
microscopy using two methods. The Leitz Ortho-
Lux microscope with a high-pressure Osram HBO 
200 mercury vapor lamp as light source was rou-
tinely employed. With this instrument violet-blue 
light in the range of 380-500 mJL was obtained with 
the use of the primary filter Schott B.G. 12. The 
secondary Schott blue-absorbing (Blau-abs) and 
UY absorbing filters were utilized in viewing char-
acteristic porphyrin fluorescence. Color photo-
graphs of fluorescent tissues were made with the 
Leitz Orthomat camera on Anscochrome 500 film. 
bections were also examined under the Wild 
M-20 microscope with a 12v /lOOW quartz-iodide 
burner (Iodine Tungsten Quartz source) using a 
Schott B.G. 12 primary and an OG-1 secondary 
filter. Both these methods of fluorescence micros-
copy were also applied in screening tests to detect 
increased erythrocyte porphyrins. 
Extraction and isolation of urinary and fecal 
porph:vrins was carried out using Rimington's 
method (10). Qualitative and quantitative P.stima-
tion of plasma and erythrocyte prophyrins was 
performed by the methods of Cripps and Peters 
( 11). Tissue porphyrins were extracted according 
to chwartz's technique (12). In spectrophoto-
metric measurement of individual porphyrinf: the 
Beckman DU spectrophotometer was utilizPd 
Animals were examined for gross evidence of 
drug toxicity. Daily records of body weight were 
kept not only for the purpose of DDC dosage de-
terminations but also in order to evaluate growth 
in experimental versus control animals. The con-
junctivae were inspected for evidence of icterus 
and routine urinalyses were carried out including 
qualitative tests for nrinary bilirubin using a com-
mercial diazo reagent.* 
RESULTS 
Porphyrin Excretion 
Marked elevation of fecal protoporphyrin 
output occurred in all animals receiving DDC. 
* Bili-test tablets. Scientific Products. 
Significant increases in the fecal content of this 
porphyrin were found within 3-4 days after 
the chemical treatment had been started (Fig. 
2). Thereafter the protoporphyrin content of 
the feces varied from day to day, but was sig-
nificantly increased above the pre-treatment 
levels and above that of the control animals. 
No uniform relationship was found between 
the fecal protoporphyrin concentration and 
either the duration or the level of DDC intake. 
Fecal coproporphyrin content was not sig-
nificantly increased and only trace amounts of 
uroporphyrin were found in the feces. Overt 
urinary porphyria was not observed. During 
the course of the experiments, mall increase 
in the urinary copro and uroporphyrin, over 
the baseline values, were found not only in the 
experimental but also in the control pigs. The 
differences between the urinary output of 
porphyrins in the experimental and control 
groups were not significant (Table II) . 
Blood Porphyrins 
The fluorescence microscopy screening test 
for in,..reased erythrocyte porphyrins ( 11) was 
negative in DDC-treated and control animals. 
Erythrocyte porphyrins were not increased by 
DDC admini tration either befor or after 
"blue light" irradiation (Fig. 3). In particular 
no significant differences were found between 
the erythrocyte protoporphyrins in the experi-
mental and control animals. The levels of 
erythrocyte porphyrins showed marked inter-
subject vanatwn (Table III). Decreases, 
rather than increases, in erythrocyte protopor-
phyrin and coproporphyrin levels occurred 
·with time in both tbe experimental and control 
groups. In the last study, where three different 
levels of DDC were employed, only animals on 
the highest. dose, viz., 400 mgjkg had meas-
urable amonnts of protoporphyrin in the 
pia rna (2. -4.71 /Lg/ 100 ml). Determination 
of pla ma porphyrins was complicated by the 
presence of a polar metabolite of DDC in the 
plasma which had a11 intense bluish fluores-
cence. 
P ho tosensiti vity 
Test exposures of the experimental animals 
to "blue light" evoked a phototoxic reaction. 
This reaction was characterized by immediate 
postirradiation erythema, lasting one to four 
hours; edema of the exposed sites which was 
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Fro. 2. Urinary and fecal porphyrin excretion of pig 36-9, before and after administration 
of DC at a do of 200. mg/ kg. ~~ssive increases in the protoporphyrin content of the f c are shown to occur w1th chrome mtake of the porphyrogen. 
maximal after 24 hour and a deep suffusion 
rythema. which appeared after 24 hours and 
wa maximal at 42-4 hours. Reactivation of 
th d lay d erythema occurred when the ani-
mal w r expo ed to daylight. Residual pig-
m ntation v.:a pre ent in animals expo ed to 
multipl "blue bo-ht" irradiations. The magni-
tud of th phototoxic reaction varied not only 
with th duration of irradiation, but al o the 
int n ity of the edema and the delayed ery-
thema varied with th intake of DDC. Thu 
ix hour irradiation at a fixed kin di tance of 
m. was requir d to induce a 'maximal ' 
r n tion in pirr r ceiving DDC at a do e of 200 
m j ko- \vh reaN the arne r action could be in-
duced aft r three hour irradiation in animal 
r n IDO' C at a do e of 400 mo-j ko-. Mini-
mal r tion were induced in the pio- re-
cervmg DDC at a dose of 100 mg/kg even 
after ix hours of irradiation (Fig. 4). 
Drug Tolerance 
There wa no ignifi.cant difference in weight 
gain between the DDC-treated and the con-
trol pigs. The magnitude of weight gain was a 
function of the caloric intake. Growth failure 
occurred in one experimental animal included 
in the third tudy, but this could be attributed 
to pre-treatment diarrhea which necessitated 
reduction in the daily volume of formula. The 
ign of DDC-intoxication which have been en-
countered in rat , viz., icteru and oliguria, 
\Yere not found in the pigs. Prolonged DDC 
inta.ke wa associated with constipation. No 
neuroloo-ical ignN were ob erved. 
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TABLE II 
PorphyTin excTetion in DDC-t1·eated and contml pigs (studies 1, 2 and 3) 
Urinary porphyrins 
p.g/ 24 hrs. 
Fecal porphyrins 
p.g/grn dry wt. 
Group Animals Co pro Uro Co pro Proto 
A B A B A B A B 
I (DDC- 5 3.97 11.90 1.54 7 .86 3.41 4.52 9.15 332.34 
t reated) ± 2.35 ± 9.55 ± 1.50 ± 6.55 ± 3.28 ± 4. 07 ± 4.42 ± 18 .69 
n 8 26 8 18 9 26 9 26 
II (controls ) 4 3 .72 7.35 2.06 3.84 2.94 1. 28 10 .21 3.97 
± 2.87 ± 5 .88 ± 1.57 ± 3.18 ± 2.97 ± 1.00 ± 7.-1:6 ± 2.46 
n 6 22 6 22 6 27 6 30 
p N.S. N.S. N .S. N.S. N.S. N .S. N.R . < 0.001 
Group I received DDC at a dose of 200 mg/ kg/ 24 hrs. 
A = baseline (pre-treatment) values [Mean ± R.E.]. 
B = values 5th- 20th days post-treatment vs cont rols [Mean± S.E.]. 
n = number of 24 hourly samples analyzed. 
P = values obtained by group comparison of experimental and control animals using tudent' t test . 
N .S. = not significant by Student's test (P > 0.05). 
Necropsy Findings 
I) The hepatobiliary system. Hepatomeg-
aly occurred in DDC-treated pigs (Fig. 5) . 
When thi porphyrogenic agent was adminis-
tered at ascending dosage levels (study 4), a 
log-dose response was obtained with relation to 
the total wet weight of the liver. The liYers of 
the experimental animals had a characteristic 
red-brown appearance and were firmer in con-
sistency than the control livers. In pigs kept on 
DDC fo r 24 or more days at a level of 200 mg/ 
kg, the liver surface had a fine cobble~tone ap-
pearance. Naked eye porphyrin fluorescence of 
the liver parenchyma was only present in pigs 
that had received DDC at the maximal dosage 
( 400 mg/ kg) . 
In fixed liver sections the characteristic 
pathological lesion was largely limited to the 
portal triads. Biliary hyperplasia was evident 
and around the bile ducts there was a mono-
nuclear infiltrate of histiocytes, lymphocytes 
and macrophages (Fig. 6). These changes were 
minimal in the livers of pigs on the lowest drug 
dose (100 mg/ kg). In pigs on the highest dose 
of DDC ( 400 mgjkg) there was additional ob-
tructive pericholangiofibrosis and periportal 
focal necrose~ were present. Early biliary fibro-
si was also present in the livers of pigs main-
tained on DDC at t he intermediate do~age 
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FIG. 3. Erythrocyte protoporphyrin ·levels in ex-
perimental and control pigs. (Values for p~gs re-
ceiving DDC at a dose of 400 mg/ kg are omitted .) 
No significant alteration in the erythrocyte con-
tent of this porphyrin was found due to DDC treat-
ment alone or to DDC plus "blue ligh t" irradiation . 
level (200 mg/ kg) for the maximal period, viz., 
24-29 days. 
Brown pigment masses occupied the lumen 
of the bile ducts and smaller pigment granules 
were also present in the interlobular canaliculi 
and in the macrophages in the enlarged fibrotic 
t riads. This pigment gave a positive Gmelin 
and a negative Prussian Blue reaction. The 
TABLE III 
The effect of DDC dosage level on urin m·y, f ecal , ery thTocyte and hepalo-bili ary porphyrins (st'udy 4) 
(a) Intact animals 
DDC 
Urinary F ecal porphyrins porphyrins 
Pig dose /Jg/24 hrs. #Jg/gm dry wt . 
mg/ kg/ 
24 hrs. 
Co pro Copro Proto Co pro 
I F (7) I F (7) 
61- 7 0 0.17 0.17 1. 74 0 .78 
60- 2 0 0.15 1. 67 1.83 1.04 
61- 6 100 0 0.49 1. 24 19.46 
60- 11 100 0.10 1.13 0.63 6.42 
61-4 200 1. 89 7.36 1.42 8.53 
60- 3 200 0.17 5.13 2.65 4. 84 
61- 2 400 0.19 17. 20 3. 12 13.58 
60-12 400 0. 60 3.64 2.12 6.12 
--- ··------
I = initial porphyrin values (pre-DDC) 
F = final porphyrin values (post-DDC) 
I F (7) I F (12) 
5.94 0.78 35 .77 5.56 
7.52 4 .68 10.22 10 .33 
0.96 366.46 36 .14 15 .78 
2.60 352.01 34 .31 12.08 
11 .13 494 .90 7.18 5.66 
4.93 170 .00 37.23 13.87 
14.84 861.23 42.34 32.36 
7.68 321 .67 50.37 9.29 
Figures in p arentheses denote duration of DDC treatment in days. 
(b) Post-mortem 
Erythrocyte porphyrins Bile porphyrins Liver porphyrins (gall bladder) /Jg/ 100 mi. packed cells IJg/ml /Jg/ gm dry wt. 
Proto Uro 
Co pro Proto Uro Copro Proto Uro 
I F (12) I F (12) 
- -
98.81 31.78 12.57 15 .87 0.98 1.53 0 0 0 0 
144 .76 85.55 21. 11 1.18 1.26 1.59 0 0.14 0 .48 0 
49 .71 18.03 12.56 11 .29 1.52 65 .06 0.08 0.03 0 .04 0 
105 .73 6 .56 34.98 32.43 6 .99 70.24 1.16 0. 61 2.45 0 
99 .20 45.36 18.46 19.74 14 .55 254 .12 3.05 0.24 7.26 0.17 
107.42 70.49 16.24 30.94 15 .05 253 .56 2.13 1.39 93.93 0 
99.98 76.51 20.74 8.67 13.94 264.04 8 .75 7.60 148.62 0.11 
190 .11 150.23 16.90 16.50 7.41 40 .13 0 .40 23.37 549.51 0 
Urinary uroporphyrin values not given because of post-DDC interference by a dosage dependent excretion of the fluorescent metabolite of the drug (max. abs . 360 mJ.L). 
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f'reatest amount of pigment was observed in 
~."ctions of livers from animals that received 
DDC for the longest period. Under polarized 
light the pigment masses were seen to consist 
Fra. 4. The effect of dosage level on photosensi-
tivitv reactions in DDC-treated pigs. Animals are 
seen. 26 hours after "blue light" irradiation for 3 
hours. From left to right. litter-mate pigs that re-
ceived 400, 200, 100 and 0 mg/ kg/ day of DDC for 
11 day . Extensive delayed erythema and edema 
of irradiated sites were visible only in the pig that 
received the maximal dose and limited erythema 
and edema was present in the pig that received 
200 mg/kg. There was no reaction in the other two 
animals. 
of birefrinO'ent material and in the muller piO'-
ment O'rain a ~lalte e cro fi.O'ure wa seen 
(Fig. 7). In un tained ecti on~ , mounted ither 
in buffered glycerol or in ynthetic mountinO' 
media (Permoun , Fi ~her cientifi ) , red por-
phyrin fiuore cence \\'a limited to the bile duct 
t riads except in tho e piO'" which had received 
DDC at the highest do e (Fig. ) . In the e ani-
mal only, fluore cence of the liver parenchyma 
was also seen which was maximal in the 
periportal areas. 
When the liver sections were observed with 
the Leitz microscope with the mercury vapor 
light source, the characteristic red porphyrin 
fluorescence might be de cribed as 'fading', 
though diminished intensity was only obvious 
after two hour of light exposure. Thu it was 
possible to obtain accurate photoO'raphic rec-
ord. u ino· either color or black and white film. 
In these tudies the employment of the quartz-
iodine ligh t source did not confer any advantaO'e 
with respect to the localization of porphyrin 
but was a less satisfactory instrumentation for 
the detailed stud~· of abnonnal liver porphyrin 
deposition. 
The gall bladder, cystic duct, the common 
bile duct and its branches exhibited intense 
porphyrin fluorescence in all the DDC-treated 
pigs. In these experimental animals the bile 
within the gall bladder was reddish-brown in 
color and contained a coarse black precipitate. 
FIG 5 Liver morphology in DDC-treated vs. control pigs. Leftr-liver from pig (36-9) 
that r~ce.ived DDC for 29 days (200 mg/kg). Rightr-liver of control ~mal (36-.1). Enlarge-
ment dark discoloration and the 'cobblestone' surface charactenzed the hver of the 
' porphyric animal. 
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F1a. 6. High power view of liver section from DDC-treated pig (36-9). Pigment mas es 
are seen within and around the bile ductules and the mononuclear stromal infiltrate is evi-dent (H and E X 800). 
Fw. 7. Liver ection from pig 36-9 seen under polarized light. Birefrin ent cry talline de-
po it howin(T Malt e cro figure is een in the tromal infiltrate surrounding a bile duct (Hand EX 1400). 
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Fra. 8. Fluorescence photomicrograph of liver from pig given DDC for 11 days at a dose 
of 200 mg/ kg (60-3) . A portal tract is shown with a porphyrin depo it within a bile duct 
(right) and a larger stromal deposit of porphyrin (left). Both of the e dcpo its showed 
characteristic intense red fluorescence. 
Microscopic examination of this precipitate 
showed it to consist in part of birefringent 
crystalline aggregates. The total bile precipi-
tate was solubl e in 3:\ .HCl to give a highly 
fluorescent olution. The total porphyrins in 
the gall bladder bile were greatly increased in 
the experimental animals. The ratio of proto to 
coproporphyrin in the bile was also altered re-
flecting a massive increase in the protoporphy-
rin and a moderate increase in coproporphyrin 
induced by the porphyrogenic agent. Small 
amount of uroporphyrin were also isolated 
from the bile of treated but not that of the 
control pigs (Fig . 9) . 
Increase in the porphyrin content of the 
liver \Ya also found in porphyric pigs and in 
t his tissue, as in the bile, the major increa e 
was in the protoporphyrin fraction. The 
amount of porphyrin in the liver was depend-
ent on the do age level of DDC admini tered. 
However, it i apparent from T able III that 
although the levels of porphyrin and particu-
larly protoporphyrin in the bile and in t he 
fece are dependent on the dosage of the por-
phyrogenic agent, that with hepatic deposition 
of protoporphyrin, this relation hip is lost. The 
impact of DDC on porphyrin production and 
accumulation ,,·ithin the hepatobiliary ystem 
appenr::; to v:u~· between pig litters of the same 
strain thu · precluding correlation of the data 
available (Figs. 9 and 10). 
2) The integument. No gross porphyrin flu-
orescence wa seen in the hair, skin or other 
cutaneous appendages . Sections prepared from 
the skin of irradiated pigs which showed de-
layed erythema prior to acrifice, exhibited 
non-specific changes similar to acute solar 
dermatiti . Small quanbtie. of protoporphyrin 
" ·ere i alated from skin homogenates, derived 
from the two pigs which received DDC at a 
do. e of 400 mg/ kg, viz., 0.32-0.57 ,ug/ gm dry 
wt. The fact that no porphyrin was isolated 
from other skin samples may be dependent on 
the limitations of the extraction method. 
3) Other tissues. All DDC-treated pigs 
showed intense red fluorescence over the entire 
length of t he small intestine. Sections of lung, 
kidney, pleen and bone marrow were examined 
but no localized fluorescence or pathological 
lesion were encountered. Neither the teeth 
nor the bones showed porphyrin fluorescence. 
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The Effect of DOC Dosage Level on Bile Porphyrins - Study 4 
[Expressed as percentage of total porphyrin in Gall Bladder] 
Total J-Lg (0/o) 
0 50 100 
I 
11.29 
12.83 0 • .,. 
100~,~ ~:::~~ 
~ 200~,"'~ :~~: :~! 
400~~-~~~~:~: 
Uro ~ Copro ~ Proto 
FI ·· 9. The effect of J?D9 do ·age leYel on ):>ile porphyrins-Study 4. (Expressed as per-
centage of tot~l J?Orphyrm m gall bladder.) F1gure~ to the right of the histogram indicate 
total p~rph;yrm m .the gall bladder at autopsy m f.l.g. Relative decrease in total bile 
1~orphynn Ifl: on p1g on the maximal DDC do c was a sociated with rna si,·e increase in 
hv r porphyrm . 
DISCUSSION 
It ha been shown by Oni ·awa and Labbe 
that the disorder of pyrrole metabolism in-
duc<'cl by DC i:-; dependent on the inhibition 
of fcrro-protoporph~Tin chelata ·e. This re~ult ­
in tt limini ·heel incorporation of protoporphy-
rin into lH'mc (13). Granick ha uggested that 
Uti ' collidinc deriYative i rrversibly bound to 
the h<'mc template (1-!). Bn .. ccl on the theory 
of .Jaeob :mel :\1onod (15) this author ha po~·­
tulatc l that the normal end 11roduct repression 
f p rphyrin ynthc i. is thereby dimini heel. 
Th 1'le oncept rxplain the acc~mulation of 
1 rotoporphyrin in the 1in'r \\·h re heme yn-
thc i i n~ry actiYe. ElrYation of biliary .co-
proporphyrin and the appearance of biliarv 
uroporph~'rin may reflect incrm eel hepatic pm:_ 
ph~·rin production econcla ry to d pre sian of 
th normal f dback mechanism. 
Thi i the fir t re] ort of hemicallY-induced 
porph ·ria in piO' . The h pati porp-hyria in-
due d b~· the collidin derivatiYe DD ha 
... imilnr bio h mien!, photobioloO'icnl and path-
oloO'ical charncteri tic in the" animal to that 
induced by DDC in other species (6, 7, 8, 9). 
The defect in pyrrole metabolism is manifested 
primarily as a protoporphyria of hepatic 
origin. Protoporphyrin which bas accumulated 
in the hepatobiliary system is excreted into the 
inte tine via the bile, and hence appears in the 
feces. Uptake of the porphyrin into the paren-
chymal cells of the liver may not only be de-
pendent on obstruction of the intra-hepatic 
biliary system but also associated with liver cell 
damage. The variable daily protoporphyrin 
content of the feces can be explained by in-
termittent expulsion of the O'all bladder con-
tents due to partial blockage of the cystic duct 
with the porphyrin precipitate. 
Since irradiation from a visible light ource, 
having a maximal emission between 400 and 
500 n.m., evoked a phototoxic reaction, it is 
sugge ted that photosensitivity is a sociated 
with porphyria and i not due to a direct pho-
totoxic response to DDC (1). The evolution of 
the cutaneous reaction, as well as the finding of 
protoporphyrin in the skin of the animals 
bowing the maximal response, lend support to 
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lhis concept . How the protoporphyrin reaches 
the skin is not clear, but it is to be noted that 
the animals on maximal DDC dosage showing 
small amounts of protoporphyrin in the skin 
\rere the arne that had measurable amounts of 
protoporphyrin in the plasma. Thus transmis-
sion of protoporphyrin to the integument via 
the plasma is suggested. The brief exposures to 
,·isible light may explain the minimal skin 
pathology. 
Although increased erythrocyte protopor-
phyrin content has been demonstrated follow-
ing DDC treatment in other species (8), no 
consistent change in erythrocyte protoporphy-
rin level was found in the present studies in 
pigs. Elevation of erythrocyte protoporphyrin 
levels, following DDC administration, may be 
pecies dependent or by analogy with the ef-
fects of griseofulvin in mice, may be contingent 
on massive drug dosage (16). 
The data presented here clearly show the 
dosage dependency of DDC-induced porphyria 
and of the attendant photosensitivity. These 
findings have practical implications, suggesting 
that dosage dependent porphyrias may also 
occur with chemically related drugs such as 
griseofulvin (17, 18). 
This experimental porphyria does resemble 
in certain respects the congenital erythropoietic 
protoporphyria (EPP) of human subjects. 
triking similarities exist between the type of 
photosen itiYity as well as the hepato-biliary 
changes in t he human and pig diseases . Cripps 
and Scheuer as well as other authors have de-
scribed t he morphology of the hepatic lesion in 
EPP, which is identical with that of the DDC 
treated animals. These authors have stressed 
the high incidence of protoporphyrin-contain-
ing gallstones in the human disease (19, 20, 21). 
Abnormal hepatic synthesis of protoporphy-
rin has been demonst rated in EPP by isotopic 
techniques (22). It has also been shown by 
Redeker and Sterling that in this disease, the 
fecal output of protoporphyrin is increased by 
caloric rest riction and decreased by high caloric 
diets (23). These authors therefore postulated 
that the excess fecal protoporphyrin was 
formed at a site subject to (lthe glucose effect" 
(24) and ugge ted primary hepatic protopor-
phyrin synthesis. Recently, Scholnick et al. pro-
duced direct biochemical evidence that a major 
portion of the protoporphyrin in EPP is of 
Dosage Dependency of Changes Induced 
by DOC in Hepatobiliary System (Study4) 
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FIG. 10. Dosage dependency of changes induced 
by DDC in hepatobiliary system (Study 4). The 
accumulation of porphyrins in the bile and liver 
is seen to vary not only with drug dose but also 
between pigs from different litters. 
hepatic origin (25). From kinetic and isotopic 
data, they showed that the liver contains a 
relatively large pool of protoporphyrin with a 
rapid turnover, accounting fo r most of the 
fecal and plasma protoporphyrin. Since their 
results clearly indicate two sources of proto-
porphyrin, i.e. one in the erythroid cells and a 
second in the liver, they proposed a revision of 
disease nomenclature from EPP to erythro-
hepatic protoporphyria. In the light of these 
findings, it would seem that a reasonably good 
animal model for the study of EPP has been 
found. 
Finally, brief discussion of the meaning of 
genetically determined porphyria is merited. It 
has been amply demonstrated that DDC can 
induce porphyria in various animal species and 
in different members of the same species, viz., 
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miniature and Yorkshire pigs. This acquired 
porphyria b ar no relationship to the domi-
nant congenital porphyria of pigs; a disease 
characterized by deposition of porphyrin in 
the bone. , teeth and pleen, as well as the 
urinary xcr tion of exces uroporphyrins and 
coproporphyrin" (3) . In the congenital por-
phyria of pigs, photosensitivity has never been 
demon trat d. Our finding have shown that 
even in animal without a porphyric trait bio-
ch mical indiYiduality may determine the im-
pact of a chemical agent on pyrrole metabo-
li m. 
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